NCT04842422已完成4 期
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
Medical University of Graz1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2021年4月16日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- immunomodulatory-induced inflammatory reaction
研究概览
简要总结
Earliest Stage Treatment of Actinic Keratosis with Imiquimod 3.75% Cream:
The study is to demonstrate that Aktinic Keratosis are present before they are clinically visible, i.e. in a subclinical stage. Since on the basis of the research situation, also subclinical AK can proliferate into the dermis, it is possible that with the application of Imiquimod on chronically light-exposed skin, undetected squamous cell carcinoma can be recognized and treated at the same time.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Earliest Stage Treatment of Aktinic Keratosis
Experimental
干预措施: Imiquimod 3.75% Cream (Drug)
结局指标
主要结局
immunomodulatory-induced inflammatory reaction
时间窗: two weeks
Percentage of subjects in whom an immunomodulatory-induced inflammatory reaction occurs on chronically light-exposed uv-damaged facial skin after two weeks.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)Actinic KeratosisNCT00603798Graceway Pharmaceuticals, LLC490
已完成
3 期
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)Actinic KeratosesNCT00605176Graceway Pharmaceuticals, LLC479
已完成
不适用
Imiquimod and Actinic Keratoses: an Observational StudyActinic KeratosisNCT01151956Federal University Teaching Hospital, Feldkirch, Austria463
终止
4 期
Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant RecipientsActinic KeratosesNCT01538901Medical University of Vienna10
已完成
3 期
Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic KeratosesActinic KeratosesNCT00175643University of British Columbia20